Volume 79, Number 9, August 28, 2012
About this course
- Released: 08/27/2012
- Expires: 08/28/2014
Learning Objectives:
Upon completion of the article by Roth et al, the participant should be able to:
• State the most typical current initial treatment of patients with primary CNS lymphoma
• Discuss any differences in toxicities of treatment in elderly, compared to younger patients with primary CNS lymphoma in this study
• Discuss the differences in outcomes among elderly, compared to younger patients with primary CNS lymphoma in this study
Core Competencies:
The article by Roth et al covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Kelly et al, the participant should be able to:
• Recognize that the Center for Medicare and Medicaid Services (CMS) is developing a 30-day risk-adjusted stroke mortality measure for public reporting purposes
• State the patient characteristics that were associated with death or discharge to hospice among the stroke patients in this study
• Discuss the findings from this study regarding a “withdrawal of care” bias and early stroke mortality
Core Competencies:
The article by Kelly et al covers the following core competency:
• Medical Knowledge
• Systems-based practice
Author Disclosures
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
